Trial intelligence / Profile preview

Immune Dysfunction in HIV+ Opioid Users

NCT04304768Phase 4Active, not recruiting

Sponsor
University of Miami
Start
Nov 2020
Primary completion
Jan 2027
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated) in influenza, sponsored by University of Miami. Started Nov 2020; status: active, not recruiting.

02

Drugs

Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)
03

Conditions

influenza

Beyond the preview

Go deeper on NCT04304768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04304768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call